Loading clinical trials...
Loading clinical trials...
A Phase 1 Study: The Determination of the Maximum Tolerable Dosage of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury
Conditions
Interventions
Sodium Nitroprusside
Locations
1
Canada
Mount Sinai Hospital, University of Toronto
Toronto, Ontario, Canada
Start Date
May 1, 2012
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
June 14, 2012
NCT07450846
NCT07414056
NCT06701669
NCT07262541
NCT06750536
NCT07086755
Lead Sponsor
Mount Sinai Hospital, Canada
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions